Discovery of a Biologically Active Bromodomain Inhibitor by Target-Directed Dynamic Combinatorial Chemistry.

ACS Med Chem Lett

Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, CONICET, Suipacha 531, S2002LRK Rosario, Argentina.

Published: October 2018

Target-directed dynamic combinatorial chemistry (DCC) has emerged as a strategy for the identification of inhibitors of relevant therapeutic targets. In this contribution, we use this strategy for the identification of a high-affinity binder of a parasite target, the bromodomain-containing protein BDF3. This protein is essential for viability of , the protozoan parasite that causes Chagas disease. A small dynamic library of acylhydrazones was prepared from aldehydes and acylhydrazides at neutral pH in the presence of aniline. The most amplified library member shows (a) high affinity for the template, (b) interesting antiparasitic activity against different parasite forms, and (c) low toxicity against Vero cells. In addition, parasites are rescued from the compound toxicity by BDF3 overexpression, suggesting that the toxicity of this compound is due to the BDF3 inhibition, i.e., the binding event that initially drives the molecular amplification is reproduced in the parasite, leading to selective toxicity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187412PMC
http://dx.doi.org/10.1021/acsmedchemlett.8b00247DOI Listing

Publication Analysis

Top Keywords

target-directed dynamic
8
dynamic combinatorial
8
combinatorial chemistry
8
strategy identification
8
discovery biologically
4
biologically active
4
active bromodomain
4
bromodomain inhibitor
4
inhibitor target-directed
4
chemistry target-directed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!